<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>Oral Cancer News</title>
	
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Thu, 12 Nov 2009 02:12:24 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/oralcancernews/KsIl" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
		<title>Brachial plexus injury may be underreported following radiation therapy in patients with head and neck cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/3xZF49YO9x8/</link>
		<comments>http://oralcancernews.org/wp/brachial-plexus-injury-may-be-underreported-following-radiation-therapy-in-patients-with-head-and-neck-cancer/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 02:12:24 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[brachial plexopathy]]></category>
		<category><![CDATA[brachial plexus]]></category>
		<category><![CDATA[nerve]]></category>
		<category><![CDATA[numbness]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7336</guid>
		<description><![CDATA[Source: www.docguide.com
Author: John Otrompke
Radiation therapy for head and neck cancer may cause an injury to the brachial plexus nerve network in as many as 20% of patients, researchers stated here at the American Society of Therapeutic Radiology and Oncology (ASTRO) 51st Annual Meeting. The incidence of the condition, characterised by numbness in the arms, inability [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/brachial-plexus-injury-may-be-underreported-following-radiation-therapy-in-patients-with-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/brachial-plexus-injury-may-be-underreported-following-radiation-therapy-in-patients-with-head-and-neck-cancer/</feedburner:origLink></item>
		<item>
		<title>Chemo treatments lengthen lives for head, neck cancer patients</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/lKYRdTPdiZE/</link>
		<comments>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:29:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7315</guid>
		<description><![CDATA[Source: www.privatemdlabs.com
Author:  Brendan Missett
Patients with head and neck cancer receiving a combined treatment of chemotherapy and radiation may live 2.1 years longer than those treated only with radiotherapy, new research suggests.
The study, published in the October 27 issue of The Lancet Oncology, separated 966 patients with advanced head and neck cancer into four treatment [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/</feedburner:origLink></item>
		<item>
		<title>Access Pharmaceuticals provides update on MuGard commercial launch in North America</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/BVbaUDK_i8I/</link>
		<comments>http://oralcancernews.org/wp/access-pharmaceuticals-provides-update-on-mugard-commercial-launch-in-north-america/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:29:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[mucoadhesive]]></category>
		<category><![CDATA[MuGard]]></category>
		<category><![CDATA[oral mucositis]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7329</guid>
		<description><![CDATA[Source: money.cnn.com
Author: press release
Access Pharmaceuticals, Inc., today provided an update on its North American commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy. Access intends to commercially launch MuGard in North America in the first quarter of 2010. Key strategic items pertaining to the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/access-pharmaceuticals-provides-update-on-mugard-commercial-launch-in-north-america/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/access-pharmaceuticals-provides-update-on-mugard-commercial-launch-in-north-america/</feedburner:origLink></item>
		<item>
		<title>National Comprehensive Cancer Network receives research grant to evaluate pralatrexate in solid tumors and hematologic malignancies</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/v7HfKNcUjak/</link>
		<comments>http://oralcancernews.org/wp/national-comprehensive-cancer-network-receives-research-grant-to-evaluate-pralatrexate-in-solid-tumors-and-hematologic-malignancies/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 16:03:52 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[antifolate]]></category>
		<category><![CDATA[pralatrexate]]></category>
		<category><![CDATA[solid tumors]]></category>
		<category><![CDATA[targeted therapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7323</guid>
		<description><![CDATA[Source; au.sys-con.com
Author: PRNewswire press release 
The National Comprehensive Cancer Network (NCCN) has been awarded a research grant from Allos Therapeutics, Inc. to support clinical studies of pralatrexate (FOLOTYN(TM), Allos Therapeutics, Inc.) in the treatment of select hematologic malignancies and solid tumors. 
Pralatrexate was recently approved by the FDA to treat patients with relapsed or refractory [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/national-comprehensive-cancer-network-receives-research-grant-to-evaluate-pralatrexate-in-solid-tumors-and-hematologic-malignancies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/national-comprehensive-cancer-network-receives-research-grant-to-evaluate-pralatrexate-in-solid-tumors-and-hematologic-malignancies/</feedburner:origLink></item>
		<item>
		<title>Intensity-modulated radiation offers treatment advantages over conventional therapy for head and neck cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/auDnczYBdRA/</link>
		<comments>http://oralcancernews.org/wp/intensity-modulated-radiation-offers-treatment-advantages-over-conventional-therapy-for-head-and-neck-cancer/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 15:45:27 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[dermatitis]]></category>
		<category><![CDATA[IMRT]]></category>
		<category><![CDATA[intensity-modulated radiation therapy]]></category>
		<category><![CDATA[local recurrence]]></category>
		<category><![CDATA[Parotid gland]]></category>
		<category><![CDATA[salivary function]]></category>
		<category><![CDATA[survival]]></category>
		<category><![CDATA[xerostomia]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7319</guid>
		<description><![CDATA[Source: www.docguide.com
Author: John Otrompke
Patients treated with simultaneously integrated boost treatment using intensity-modulated radiation therapy (IMRT) experience better overall survival, disease-free survival, and local recurrence rates, as well as decreased dermatitis and better postoperative salivary function that those treated with conventional radiation.
&#8220;IMRT treatment was described as &#8216;boosted&#8217; because we use 2 different doses in the same [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/intensity-modulated-radiation-offers-treatment-advantages-over-conventional-therapy-for-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/intensity-modulated-radiation-offers-treatment-advantages-over-conventional-therapy-for-head-and-neck-cancer/</feedburner:origLink></item>
		<item>
		<title>Weekly radiation of more than 10 gy improves local control in head and neck cancer patients</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/o8ZWW1anKVc/</link>
		<comments>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 14:50:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[dose]]></category>
		<category><![CDATA[dysphagia]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7310</guid>
		<description><![CDATA[Source: www.docguide.com
Author: John Otrompke
Patients with head and neck squamous cell carcinoma who receive an average weekly fractionated radiation dose of more than 10 gy experience significantly better local control at 2 years, unless they are receiving chemotherapy at the same time, according to a study presented here at the American Society of Therapeutic Radiology and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/</feedburner:origLink></item>
		<item>
		<title>HPV vaccine clears viral infection and may reduce cancerous lesions</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/Pt1kwujMTTU/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 03:37:37 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[regression]]></category>
		<category><![CDATA[synthetic long peptides]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7304</guid>
		<description><![CDATA[Source: www.newswise.com
Author: staff
Breakthrough study reports complete and partial remissions following vaccination
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. 
According to a report published in the November 5 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/hpv-vaccine-clears-viral-infection-and-may-reduce-cancerous-lesions/</feedburner:origLink></item>
		<item>
		<title>Report highlights cancer advances</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/JKz8n0YC3lA/</link>
		<comments>http://oralcancernews.org/wp/report-highlights-cancer-advances/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 15:08:06 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[gefitinib]]></category>
		<category><![CDATA[Iressa]]></category>
		<category><![CDATA[methotrexate]]></category>
		<category><![CDATA[progression-free surviva]]></category>
		<category><![CDATA[re-irradiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7295</guid>
		<description><![CDATA[Source: www.medpagetoday.com
Author: Charles Bankhead, Staff Writer, MedPage Today
As the war on cancer enters its fifth decade, 51 studies stood out as examples of progress that occurred in the past year, as determined by the American Society of Clinical Oncology (ASCO) and reported in &#8220;Clinical Cancer Advances 2009.&#8221;
Reflecting input from specialists throughout the field, the ASCO [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/report-highlights-cancer-advances/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/report-highlights-cancer-advances/</feedburner:origLink></item>
		<item>
		<title>The oral cancer epidemic in central and eastern Europe</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/pKFcVBU_ysE/</link>
		<comments>http://oralcancernews.org/wp/the-oral-cancer-epidemic-in-central-and-eastern-europe/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 14:56:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[europe]]></category>
		<category><![CDATA[mortality]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7291</guid>
		<description><![CDATA[Source: Int J Cancer, October 30, 2009
Author: Werner Garavello et al.
To monitor recent trends in oral and pharyngeal cancer mortality in 38 European countries, we analyzed data provided by the World Health Organization over the period 1975-2004. Joinpoint analysis was used to identify significant changes in trends. 
In the European Union (EU), male mortality rates [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-oral-cancer-epidemic-in-central-and-eastern-europe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/the-oral-cancer-epidemic-in-central-and-eastern-europe/</feedburner:origLink></item>
		<item>
		<title>Does green tea prevent cancer?</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/jUqmGDObJyc/</link>
		<comments>http://oralcancernews.org/wp/does-green-tea-prevent-cancer/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 21:03:35 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[clinical response]]></category>
		<category><![CDATA[dysplasia]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[green tea extract]]></category>
		<category><![CDATA[pre-malignant lesions]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7286</guid>
		<description><![CDATA[Source: www.ivanhoe.com
Author: staff
Evidence continues to brew about the protective effects of green tea against cancer, but scientists are still not sure the tea leaves reveal the answer.
Vassiliki Papadimitrakopoulo, M.D., professor of medicine in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas M. D. Anderson Cancer Center, and colleagues tested 41 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/does-green-tea-prevent-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/does-green-tea-prevent-cancer/</feedburner:origLink></item>
		<item>
		<title>Hookah myths go up in smoke</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/cYK8PF09wWs/</link>
		<comments>http://oralcancernews.org/wp/hookah-myths-go-up-in-smoke/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 20:59:18 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cigarettes]]></category>
		<category><![CDATA[hookah]]></category>
		<category><![CDATA[shisha]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7281</guid>
		<description><![CDATA[Source:
Author: Kate Dopazo
Students, university health officials discuss misconceptions about smoking hookah
When Rajiv Ulpe, a public and community health master’s student, asked students to compare hookah to cigarettes Friday afternoon at a lecture on the campus, most attendees agreed hookah was a much healthier alternative to smoking cigarettes.
“I don’t think you can get addicted to hookah,” [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hookah-myths-go-up-in-smoke/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/hookah-myths-go-up-in-smoke/</feedburner:origLink></item>
		<item>
		<title>Dentists your first defence in fight against oral cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/KFMkzwL8Ic4/</link>
		<comments>http://oralcancernews.org/wp/dentists-your-first-defence-in-fight-against-oral-cancer/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 19:23:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[calluses]]></category>
		<category><![CDATA[early detection]]></category>
		<category><![CDATA[erythroplakia]]></category>
		<category><![CDATA[leukoplakia]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[pre-malignant lesions]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7278</guid>
		<description><![CDATA[Source: Timescolonist
Author: Johnathan Skuba
In 2003, an estimated 3,100 Canadians were newly diagnosed with oral cancer. That same year, 1,090 people died of the disease. In the U.S., oral cancer kills roughly one person per hour, 24 hours a day. Of those newly diagnosed, only half will survive five years later, and this terrifying death rate [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/dentists-your-first-defence-in-fight-against-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/dentists-your-first-defence-in-fight-against-oral-cancer/</feedburner:origLink></item>
		<item>
		<title>“French” kissing ups risk of oral HPV infection</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/T_kWdWZBZYk/</link>
		<comments>http://oralcancernews.org/wp/french-kissing-ups-risk-of-oral-hpv-infection-2/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 19:12:19 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA["French" kissing]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[Dr. Maura L. Gillison]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[oral sex]]></category>
		<category><![CDATA[The Ohio State University]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7276</guid>
		<description><![CDATA[Source: The Journal of Infectious Diseases
Author: Staff
NEW YORK (Reuters Health) &#8211; Oral sex and open-mouthed &#8220;French&#8221; kissing increase the risk of acquiring oral infections of human papillomavirus, or HPV, a study shows.
&#8220;Performing oral sex is not without risks,&#8221; Dr. Maura L. Gillison told Reuters Health.
It is associated with gonorrheal pharyngitis &#8211; a sexually transmitted infection [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/french-kissing-ups-risk-of-oral-hpv-infection-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/french-kissing-ups-risk-of-oral-hpv-infection-2/</feedburner:origLink></item>
		<item>
		<title>Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/sCVmaoZ2GiU/</link>
		<comments>http://oralcancernews.org/wp/incidence-of-carcinoma-of-the-major-salivary-glands-according-to-the-who-classification-1992-to-2006-a-population-based-study-in-the-united-states/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 18:43:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[adenoid cystic carcinoma]]></category>
		<category><![CDATA[carcinoma]]></category>
		<category><![CDATA[M-SGC]]></category>
		<category><![CDATA[salivary gland]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7273</guid>
		<description><![CDATA[Source: CEBP.com
Author: Staff
Requests for reprints:
Graça M. Dores, Medical Service (111), Department of Veterans Affairs Medical Center, 921 North East 13th Street, Oklahoma City, OK 73104. Phone: 405-456-3325. E-mail: doresg@mail.nih.gov
Abstract
Background: Carcinomas of the major salivary glands (M-SGC) comprise a morphologically diverse group of rare tumors of largely unknown cause. To gain insight into etiology, we evaluated [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/incidence-of-carcinoma-of-the-major-salivary-glands-according-to-the-who-classification-1992-to-2006-a-population-based-study-in-the-united-states/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/incidence-of-carcinoma-of-the-major-salivary-glands-according-to-the-who-classification-1992-to-2006-a-population-based-study-in-the-united-states/</feedburner:origLink></item>
		<item>
		<title>GenVec receives orphan drug designation</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/9vVdx9PCx5Y/</link>
		<comments>http://oralcancernews.org/wp/genvec-receives-orphan-drug-designation/#comments</comments>
		<pubDate>Sun, 08 Nov 2009 19:07:30 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[immune system]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[TNFerade]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7269</guid>
		<description><![CDATA[Source: www.onemedplace.com
Author: staff
GenVec’s experimental drug to treat pancreatic cancer has been granted orphan drug status by the U.S. Food and Drug Administration (FDA).  The drug candidate TNFerade stimulates the production of an immune system protein known for having anti-cancer effects.  Shares in GenVec rose 25 percent following the announcement.   
Last summer, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/genvec-receives-orphan-drug-designation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/genvec-receives-orphan-drug-designation/</feedburner:origLink></item>
	</channel>
</rss>
